Archer Investment Corp »

Eagle Pharmaceuticals shares owned by Archer Investment Corp

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Archer Investment Corp from 13F filings

Historical chart of Archer Investment Corp investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Archer Investment Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Archer Investment Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8k 350 5.23
2023-09-30 $5.5k 350 15.77
2023-06-30 $5.7k 293 19.44
2023-03-31 $8.3k 293 28.37

More positions owned by Archer Investment Corp

First Tr Exchange-traded Fd Cap Strength Etf Etf (FTCS)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
First Tr Exchange Traded Fd Viii Ft Cboe Vst Us Eqt Modrat Buf Etf Etf (GAUG)
Invesco Exchange Traded Fd Tr S&p500 Eql Wgt Etf (RSP)
Ishares Tr 0-3 Mnth Treasry Etf (SGOV)
Apple (AAPL)
Prologis Reit (PLD)
Innovator Etfs Tr Us Eqt Ultra Bf Etf (UAUG)
First Tr Exchange Traded Fd Iii First Tr Pfd Secs & Income Etf Etf (FPE)
Microsoft Corporation (MSFT)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Ishares Russell 2000 Etf Etf (IWM)
First Tr Exch Trd Alphdx Fd Ii India Nfty50 Eqw Etf (NFTY)
First Trust Tcw Opp Fixed In Etf (FIXD)
Vanguard Specialized Funds Div App Etf Etf (VIG)

View all positions for Archer Investment Corp

Top funds holding Eagle Pharmaceuticals

Henderson Group
Brandes Investment Partners
Vanguard Group
Millennium Management
AQR Capital Management
LSV Asset Management
J. Goldman & Co
Dimensional Fund Advisors
Two Sigma Advisers
Two Sigma Investments
Goldman Sachs Group
Thomas Stevens, CFA"
Bank of America Corporation
Assenagon Asset Management
D. E. Shaw & Co

View all funds holding Eagle Pharmaceuticals